Status:
UNKNOWN
Chromosomal Instability in Ovarian Cancer
Lead Sponsor:
Lei Li
Conditions:
Epithelial Ovarian Cancer
High-grade Serous Ovarian Carcinoma
Eligibility:
FEMALE
18+ years
Brief Summary
Chromosomal instability (CIN) refers to the ongoing genomic change, which involves the amplification or deletion of chromosome copy number or structure. The changes rang from point mutation to small-s...
Eligibility Criteria
Inclusion
- Confirmed of primary ovarian high grade serous carcinoma (HGSC)
- Aged 18 years or older
- Acceptance of surgical treatment for HGSC
- With detailed follow-up outcomes
Exclusion
- Not meeting all of the inclusion criteria
- Declining to anticipate the trial
Key Trial Info
Start Date :
March 26 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 26 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05310357
Start Date
March 26 2022
End Date
March 26 2024
Last Update
April 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lei Li
Beijing, Beijing Municipality, China, 100730